Jump to navigation ☰ Menu Scientific Advisory As part of its collaborative approach to advancing evidence-based products, Biostage has formed a Scientific Advisory Board (SAB) to benefit from working closely with third party experts having extensive scientific and medical expertise and transplantation experience. Dr. Joseph Vacanti joined the SAB as Chairman in November 2015. The company plans to name additional members to the SAB during the next 12 to 18 months. Stephen F. Badylak DVM, PhD, MD Co-Chairman Joseph Philip Vacanti, MD Co-Chairman Charles S. Cox, Jr., MD Christine Finck, MD Loading... Privacy Policy Terms of Use Search Contact ©2021 Biostage. All rights reserved.

Jump to navigation ☰ Menu Contact Biostage, Inc. 84 October Hill Road Holliston, Massachusetts 01746 United States Phone: 774.233.7300 Toll Free:855.209.3104 Fax: 774.233.7302 Privacy Policy Terms of Use Search Contact ©2021 Biostage. All rights reserved.

Jump to navigation ☰ Menu Press Releases Email Alerts Year All Years 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 Keywords Go Advanced Search NOV 15, 2021 Biostage Reports Q3 2021 Financial Results Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Cellframe™ and Cellspan™ technology, today... SEP 8, 2021 Biostage™ Appoints Jerry He to Board of Directors and Completes Private Placement of $2.6 Million to Continue Its Clinical Transition Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing novel organ regeneration technology based its patented Cellframe™ and Cellspan™ technology,... AUG 13, 2021 Biostage Reports Q2 2021 Financial Results Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Cellframe™ and Cellspan™ technology, today... MAY 24, 2021 Biostage Reports Q1 2021 Financial Results Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Cellframe™ and Cellspan™ technology, today... APR 13, 2021 Biostage Reports 2020 Financial Results and Appointment of Interim Vice President of Finance Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing next-generation bioengineered esophageal implants, today announced its financial results for the... Show 5 per page «123456789…34» Privacy Policy Terms of Use Search Contact ©2021 Biostage. All rights reserved.